Clinical Trial Update: A Study of Lorigerlimab in Participants With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for Lorigerlimab in participants with advanced solid tumors, currently recruiting, including platinum-resistant ovarian …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Carcinoma of the Cervix
• Clear Cell Carcinoma of the Ovary
• Clear Cell Carcinoma of the Uterus
• Clear Cell Carcinoma of the Vagina
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Lorigerlimab (lorigerlimab)

Snippet

Sponsor: MacroGenics | Conditions: Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma | Phase 2 | Status: RECRUITING